This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Novavax Vaccine to Get U.S. Approval? ETFs to Benefit
by Sanghamitra Saha
Novavax (NVAX) is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
5 ETFs to Make the Most of Thermo Fisher Deal to Buy PPD
by Sweta Killa
Thermo Fisher Scientific (TMO) has agreed to buy the healthcare testing company PPD Inc. (PPD) for $17.4 billion in cash.
What's in Store for COVID-Themed ETFs as New Cases Rise?
by Sweta Jaiswal, FRM
The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart pick.
ETFs to Buy as Zoom Shares Surge on Stellar Q4 Earnings
by Sanghamitra Saha
On Mar 1 after the bell, Zoom Video Communications (ZM) crushed estimates for its fiscal fourth-quarter earnings.
COVID-Themed ETFs in Focus Amid Soaring Cases
by Sweta Jaiswal, FRM
The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.
COVID-Themed ETFs in Focus as Cases Soar Post Thanksgiving
by Sweta Jaiswal, FRM
The rest of 2020 and the beginning of 2021 are expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.
Nvidia Q3 Earnings and Revenues Top: ETFs to Buy
by Sweta Killa
Nvidia reported solid third-quarter fiscal 2021 results, wherein it outpaced the Zacks Consensus Estimate on earnings and revenues. Management on the conference call said that data center revenues would decline in the fiscal fourth quarter.
ETFs to Watch Ahead of Nvidia's Q3 Earnings
by Sweta Killa
A few analysts like Deutsche Bank, Susquehanna raised the price target on Nvidia ahead of its Q3 earnings on its continued strength in the gaming and data center markets.
Coronavirus-Themed ETFs in Focus as the Pandemic Worsens
by Sweta Jaiswal, FRM
The remainder of 2020 is expected to continue bearing the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.
ETFs to Win From the Netflix, Amazon Q3 Earnings Faceoff
by Sweta Killa
Both companies have reasonable chances of beating earnings estimates with Netflix witnessing positive earnings estimate revisions. On the other hand, Amazon saw negative earnings estimate revision.
5 Coronavirus-Themed ETFs That Can Fight the Pandemic Scares
by Sweta Jaiswal, FRM
It feels like the rest of 2020 will continue to bear the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.
Nvidia's Buyout of Designer Arm Put These ETFs in Focus
by Sweta Killa
The news has put the spotlight on some ETFs, which could be the best ways for investors to tap the opportunity arising from the proposed Nvidia deal.
Direxion Debuts CCON ETF, Expands COVID-19-Themed Product Base
by Sweta Jaiswal, FRM
In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."
Direxion Debuts CCOC ETF, Expands COVID-19-Themed Product Base
by Sweta Jaiswal, FRM
In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."
The Zacks Analyst Blog Highlights: NVIDIA, BOTZ, SOXX, SMH and ESPO
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, BOTZ, SOXX, SMH and ESPO
ETFs to Watch Post Stellar Q2 Earnings From Nvidia
by Sweta Killa
Nvidia reported solid second-quarter fiscal 2021 results by outpacing the Zacks Consensus Estimate on earnings and revenues, and offering a solid guidance for the ongoing quarter.
Should You Invest in COVID Themed ETFs?
by Neena Mishra
We highlight three new ETFs that seek to capitalize on coronavirus
Another COVID-Themed ETF Digital Health (EDOC) Hits Market
by Sanghamitra Saha
Global X recently announced the launch of the Global X Telemedicine & Digital Health ETF (EDOC), broadening the issuer???s portfolio of thematic ETFs.
ETFs to Watch as Netflix Drops on Weak Subscriber Outlook
by Sweta Killa
While Netflix beat revenue estimates and reported solid subscriber addition, it missed the earnings estimate and offered weak third-quarter subscriber guidance.
ETFs to Buy as Netflix Tops Disney Ahead of Q2 Earnings
by Sweta Killa
The outperformance for Netflix is expected to continue given that the company has strong chances of beating estimates for the second quarter and witnessed positive earnings estimate revisions.
Top ETF Stories of 1H Likely to Rule in Second-Half 2020
by Sanghamitra Saha
Overall, the S&P 500 is down 1.6% this year (as of Jul 6, 2020) while the Nasdaq Composite has gained 16.3% in the year-to-date frame. The Dow Jones has suffered the most with 7.9% year-to-date loss.